Faraday Pharmaceuticals is a company specializing in the use of elemental reducing agents to support the quality of life after acute, critical illness. It develops FDY-5301, a therapeutic candidate that helps to destroy hydrogen peroxide and minimize damage to cardiac and skeletal muscle.